Introducing CardioCorX, one of 21 MedTech startups chosen as finalists in the 8th annual M2D2 $200K Challenge. We spoke with CEO and President, Randy Werneth, who shared the story of their innovation.
CardioCorX was chosen for their development of a simple integrative medical approach for patients suffering from atrial fibrillation with or without heart failure.